{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T23:20:31Z","timestamp":1768260031048,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T00:00:00Z","timestamp":1551139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00280-019-03803-8","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T20:49:45Z","timestamp":1551214185000},"page":"875-880","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Classification and regression tree-based prediction of 6-mercaptopurine-induced leucopenia grades in children with acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8952-9581","authenticated-orcid":false,"given":"Shaik Mohammad","family":"Naushad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patchava","family":"Dorababu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yedluri","family":"Rupasree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Addepalli","family":"Pavani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Digumarti","family":"Raghunadharao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tajamul","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman A.","family":"Alrokayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay Kumar","family":"Kutala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,26]]},"reference":[{"issue":"3","key":"3803_CR1","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00280-018-3525-8","volume":"81","author":"T Gerbek","year":"2018","unstructured":"Gerbek T, Ebbesen M, Nersting J, Frandsen TL, Appell ML, Schmiegelow K (2018) Role of TPMT and ITPA variants in mercaptopurine disposition. Cancer Chemother Pharmacol 81(3):579\u2013586","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"3803_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4103\/0971-5851.171553","volume":"36","author":"FH El-Rashedy","year":"2015","unstructured":"El-Rashedy FH, Ragab SM, Dawood AA, Temraz SA (2015) Clinical implication of thiopurine methyltransferase polymorphism in children with acute lymphoblastic leukemia: a preliminary Egyptian study. Indian J Med Paediatr Oncol 36(4):265\u2013270","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"3","key":"3803_CR3","first-page":"405","volume":"69","author":"M Chrzanowska","year":"2012","unstructured":"Chrzanowska M, Kuehn M, Januszkiewicz-Lewandowska D, Kurzawski M, Dro\u017adzik M (2012) Thiopurine S-methyltransferase phenotype-genotype correlation in children with acute lymphoblastic leukemia. Acta Pol Pharm 69(3):405\u2013410","journal-title":"Acta Pol Pharm"},{"issue":"4","key":"3803_CR4","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1365-2125.2010.03867.x","volume":"71","author":"T Adam de Beaumais","year":"2011","unstructured":"Adam de Beaumais T, Fakhoury M, Medard Y, Azougagh S, Zhang D, Yakouben K, Jacqz-Aigrain E (2011) Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy. Br J Clin Pharmacol 71(4):575\u2013584","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"3803_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00228-011-1133-1","volume":"68","author":"P Dorababu","year":"2012","unstructured":"Dorababu P, Nagesh N, Linga VG, Gundeti S, Kutala VK, Reddanna P, Digumarti R (2012) Epistatic interactions between thiopurine methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) variations determine 6-mercaptopurine toxicity in Indian children with acute lymphoblastic leukemia. Eur J Clin Pharmacol 68(4):379\u2013387","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"3803_CR6","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.2217\/pgs.12.70","volume":"13","author":"P Dorababu","year":"2012","unstructured":"Dorababu P, Naushad SM, Linga VG, Gundeti S, Nagesh N, Kutala VK, Reddanna P, Digumarti R (2012) Genetic variants of thiopurine and folate metabolic pathways determine 6-MP-mediated hematological toxicity in childhood ALL. Pharmacogenomics 13(9):1001\u20131008","journal-title":"Pharmacogenomics"},{"issue":"1","key":"3803_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/bcp.12588","volume":"80","author":"K Ogungbenro","year":"2015","unstructured":"Ogungbenro K, Aarons L, CRESim, Epi-CRESim Project Groups (2015) Physiologically based pharmacokinetic model for 6-mercaptopurine: exploring the role of genetic polymorphism in TPMT enzyme activity. Br J Clin Pharmacol 80(1):86\u2013100","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"3803_CR8","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cgh.2009.09.031","volume":"8","author":"AK Waljee","year":"2010","unstructured":"Waljee AK, Joyce JC, Wang S, Saxena A, Hart M, Zhu J, Higgins PD (2010) Algorithms outperform metabolite tests in predicting response of patients with inflammatory bowel disease to thiopurines. Clin Gastroenterol Hepatol 8(2):143\u2013150","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"3803_CR9","first-page":"929","volume":"41","author":"XL Ma","year":"2003","unstructured":"Ma XL, Zhu P, Wu MY, Li ZG, Hu YM (2003) Relationship between single nucleotide polymorphisms in thiopurine methyltransferase gene and tolerance to thiopurines in acute leukemia. Zhonghua Er Ke Za Zhi 41(12):929\u2013933","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"4","key":"3803_CR10","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.bbrc.2003.08.103","volume":"309","author":"R Hamdan-Khalil","year":"2003","unstructured":"Hamdan-Khalil R, Allorge D, Lo-Guidice JM, Cauffiez C, Chevalier D, Spire C, Houdret N, Libersa C, Lhermitte M, Colombel JF, Gala JL, Broly F (2003) In vitro characterization of four novel non-functional variants of the thiopurine S-methyltransferase. Biochem Biophys Res Commun 309(4):1005\u20131010","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"3803_CR11","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1097\/MIB.0000000000000570","volume":"21","author":"MN Lee","year":"2015","unstructured":"Lee MN, Kang B, Choi SY, Kim MJ, Woo SY, Kim JW, Choe YH, Lee SY (2015) Impact of genetic polymorphisms on 6-thioguanine nucleotide levels and toxicity in pediatric patients with IBD treated with azathioprine. Inflamm Bowel Dis 21(12):2897\u20132908","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"3803_CR12","doi-asserted-by":"publisher","first-page":"872","DOI":"10.4143\/crt.2017.283","volume":"50","author":"ES Yi","year":"2018","unstructured":"Yi ES, Choi YB, Choi R, Lee NH, Lee JW, Yoo KH, Sung KW, Lee SY, Koo HH (2018) NUDT15 variants cause hematopoietic toxicity with low 6-TGN levels in children with acute lymphoblastic leukemia. Cancer Res Treat 50(3):872\u2013882","journal-title":"Cancer Res Treat"},{"issue":"8","key":"3803_CR13","first-page":"950","volume":"58","author":"Y Tanaka","year":"2017","unstructured":"Tanaka Y (2017) Susceptibility to 6-mercaptopurine toxicity related with NUDT15 and ABCC4 variants in Japanese childhood acute lymphoblastic leukemia. Rinsho Ketsueki 58(8):950\u2013956","journal-title":"Rinsho Ketsueki"},{"key":"3803_CR14","doi-asserted-by":"publisher","first-page":"30244","DOI":"10.1038\/srep30244","volume":"6","author":"A Smid","year":"2016","unstructured":"Smid A, Karas-Kuzelicki N, Jazbec J, Mlinaric-Rascan I (2016) PACSIN2 polymorphism is associated with thiopurine-induced hematological toxicity in children with acute lymphoblastic leukaemia undergoing maintenance therapy. Sci Rep 6:30244","journal-title":"Sci Rep"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-019-03803-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-019-03803-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-019-03803-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T19:13:13Z","timestamp":1582657993000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-019-03803-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,26]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["3803"],"URL":"https:\/\/doi.org\/10.1007\/s00280-019-03803-8","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,26]]},"assertion":[{"value":"22 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}